Details

Title: Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy. A prescription for change: the looming crisis in drug development
Creators: Kinch Michael
Imprint: Chapel Hill: The University of North Carolina Press, 2016
Collection: Электронные книги зарубежных издательств; Общая коллекция
Subjects: Drug development.; Drugs — Research — Economic aspects.; Pharmaceutical industry.; Drugs — Design.; Drug Design; Drug Industry; Médicaments — Développement.; Médicaments — Recherche — Aspect économique.; Industrie pharmaceutique.; Médicaments — Conception.; MEDICAL — Pharmacology.; BUSINESS & ECONOMICS — Development — Business Development.; EBSCO eBooks
Document type: Other
File type: PDF
Language: English
Rights: Доступ по паролю из сети Интернет (чтение, печать, копирование)
Record key: ocn959609251

Allowed Actions:

pdf/1222280.pdf
Action 'Read' will be available if you login or access site from another network Action 'Download' will be available if you login or access site from another network
epub/1222280.epub
Action 'Download' will be available if you login or access site from another network

Group: Anonymous

Network: Internet

Annotation

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher.

Document access rights

Network User group Action
ILC SPbPU Local Network All Read Print Download
Internet Authorized users SPbPU Read Print Download
-> Internet Anonymous

Table of Contents

  • Cover
  • Contents
  • Acknowledgments
  • Introduction: How Did We Reach This Point?
  • Chapter One: Why Regulate Medicines?
  • Chapter Two: Trials and Tribulations
  • Chapter Three: Dreams of Greatness: The Birth of the Pharmaceutical Industry
  • Chapter Four: Triumph and Tragedy
  • Chapter Five: Ivory Tower of Power
  • Chapter Six: The DNA of Biotechnology
  • Chapter Seven: Blockbusters and Bombs: Pressures on the Pharmaceutical Industry
  • Chapter Eight: Sea Monsters, Immunauts, and Death Panels
  • Chapter Nine: Drama on the I-270 Tech Corridor
  • Chapter Ten: Autophagy
  • Chapter Eleven: Three Views of a Train Wreck
  • Chapter Twelve: Bridging the Valley
  • Notes
  • Index
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • R
    • S
    • T
    • U
    • V
    • W
    • Y
    • Z

Usage statistics

pdf/1222280.pdf

stat Access count: 0
Last 30 days: 0
Detailed usage statistics

epub/1222280.epub

stat Access count: 0
Last 30 days: 0
Detailed usage statistics